---
uid: S-001-0002
type: synthesis
title: Clinical Biochemical Assessment Framework — Integrated Protocol
aliases: [S-001-0002, Clinical-Framework, Biochemical-Assessment, Lab-Interpretation-Guide]
domain: 001
domain-name: Clinical_Assessment
tags: [synthesis, clinical-protocol, biomarkers, assessment, interpretation, phd-methap, living-document]
parent-moc: [[MOC-Clinical-Protocols]]
status: active
version: 1.1
created: 2026-03-30
last-updated: 2026-04-01
contributing-zettels:
  - "[[CBC_Interpretation_Clinical_[Z-001-0300]]]"
  - "[[Iron_Studies_Assessment_[Z-001-0301]]]"
  - "[[Lipid_Panel_Analysis_[Z-001-0302]]]"
  - "[[Metabolic_Markers_Integration_[Z-001-0303]]]"
---

# Clinical Biochemical Assessment Framework — Integrated Protocol

> **Comprehensive 10-panel biochemical assessment for metabolic health evaluation**
> 
> **Purpose:** Standardized clinical evaluation + PhD data collection  
> **Target:** Metabolic syndrome, insulin resistance, micronutrient status  
> **Frequency:** Baseline → 3mo → 6mo → 12mo

---

## The 10 Assessment Panels

### 1. Complete Blood Count (CBC)
**Purpose:** Screen for anemia, infection, hematologic disorders

| Parameter | Key Interpretation |
|-----------|-------------------|
| WBC | Infection, inflammation, immune status |
| Hematocrit | Anemia, hydration status |
| Platelets | Thrombocytosis (inflammation), thrombocytopenia |

**Patterns:**
- [[CBC_Patterns_Interpretation_[Z-000-0001]]]

---

### 2. Vitamin D Panel (High-Dose Protocol)
**Purpose:** Vitamin D status for metabolic/immune optimization

| Target | Range | Action |
|--------|-------|--------|
| **Optimal** | 80-150 ng/mL | Maintain regimen |
| **Suboptimal** | 50-80 ng/mL | Increase dose |
| **Deficient** | <30 ng/mL | High-dose protocol |

**Protocol:** [[Vitamin_D_High_Dose_Monitoring_Protocol_[Z-001-0091]]]

---

### 3. Thyroid Panel (Expanded)
**Purpose:** Comprehensive thyroid function + autoimmunity

| Pattern | TSH | fT4 | Anti-TPO/Anti-TG | Interpretation |
|---------|-----|-----|------------------|----------------|
| Euthyroid | 0.5-2.5 | Normal | Negative | ✅ Optimal |
| Subclinical hypo | 2.5-4.0 | Normal | — | Monitor |
| Overt hypothyroid | >4.0 | Low | May be + | Treat |
| Hashimoto's | Variable | Variable | Positive | Autoimmune protocol |

---

### 4. Inflammation Markers
**Purpose:** Systemic inflammation assessment

| Marker | Target | Clinical Meaning |
|--------|--------|------------------|
| CRP | <1 mg/L | Low cardiovascular risk |
| ESR | <20 mm/hr | No active inflammation |
| Homocysteine | <10 μmol/L | Methylation adequate |

**Elevated homocysteine →** Check B12, folate, MTHFR

---

### 5. Insulin Resistance Panel (PhD Core)
**Purpose:** Early IR detection before glucose rises

| Metric | Formula | Target | Interpretation |
|--------|---------|--------|----------------|
| **HOMA-IR** | (Glu×Ins)/405 | <2.0 | Primary IR index |
| **HOMA-β** | 360×Ins/(Glu-63) | 100-200 | Beta-cell function |
| **TG/HDL** | TG/HDL | <2.0 | Lipid IR marker |
| **TyG Index** | ln(TG×Glu/2) | <4.5 | Alternative IR index |

**Status Classification:**
- **No IR:** All markers optimal
- **Early IR:** HOMA-IR 2.0-2.5 OR TG/HDL >1.5
- **Established IR:** HOMA-IR >2.5 OR HbA1c >5.3
- **Metabolic Syndrome:** 3+ of 5 criteria

---

### 6. Lipid Profile & Advanced Markers
**Purpose:** Cardiovascular risk stratification

| Pattern | LDL | HDL | TG | ApoB | Interpretation |
|---------|-----|-----|-----|------|----------------|
| Pattern A | — | — | — | — | Large buoyant LDL (low risk) |
| Pattern B | — | Low | High | High | Small dense LDL (high risk) |

**Key Ratios:**
- HDL/TG >1.0 = Optimal
- LDL/ApoB >1.2 = Pattern A
- Total/HDL <4.0 = Low risk

---

### 7. Liver & Kidney Function
**Purpose:** Organ function, detoxification capacity

**Liver Patterns:**
- **Hepatocellular:** ALT>AST (fatty liver, toxins)
- **Cholestatic:** ALP+GGT high (bile issues)
- **Alcoholic:** AST:ALT >2:1

**Kidney:** eGFR >90, creatinine stable

---

### 8. Anemia & Micronutrient Panel
**Purpose:** Iron status, B-vitamins, methylation

**Iron Status Patterns:**
- **Iron deficiency:** Low ferritin, low iron, high TIBC
- **Anemia of chronic disease:** Normal/high ferritin, low iron, low TIBC
- **Iron overload:** Ferritin >150 (F), >300 (M)

**Methylation Status:**
- Optimal: Homocysteine <10, B12 >600, 5-MF >10
- MTHFR variant: High homocysteine, low 5-MF

---

### 9. Summary & Action Plan
**Output:** Priority findings + supplement protocol + retest schedule

---

### 10. PhD Data Export
**Format:** Standardized CSV for statistical analysis

**Schema:** [[METHAP_PhD_Data_Export_Structure_[Z-002-0621]]]

---

## Integration with Zettelkasten

Each panel connects to:
- Individual biomarker zettels (Z-XXX-XXXX)
- Biomarker family guides (B-XXX-XXXX)
- Mechanism zettels (pathways, physiology)
- Intervention zettels (supplements, protocols)

---

*This synthesis integrates 10 assessment panels into a coherent clinical framework for metabolic health evaluation.*
